EPA-540/1-86-015
                      Environmental Protection
                      Agency
Office of Emergency and
Remedial Response
Washington DC 20460
                      Superfund
&EPA
Off'ce of Research and Development
Office of Health and Environmental
Assessment
Environmental Criteria and
Assessment Office
Cincinnati OH 45268
                       HEALTH  EFFECTS  ASSESSMENT
                       FOR  cis-1,2-DICHLOROETHYLENE

-------
                                                                 EPA/540/1-86-015
                                                                 September  1984
                             HEALTH EFFECTS ASSESSMENT
                           FOR  CIS-1,2-DICHLOROETHYLENE
                          U.S. Environmental  Protection Agency
                           Office of Research and Development
                      Office  of Health and Environmental  Assessment
                      Environmental  Criteria  and Assessment Office
                                  Cincinnati, OH  45268
                          U.S. Environmental  Protection Agency
                        Office of  Emergency and Remedial  Response
                      Office of Solid Waste and Emergency Response
                                  Washington, DC  20460
U.S. Environment! Protection Agency
Region V,  Li'-'.-r -
230 So' 0 ••''"•*-. -.-t

-------
                                  DISCLAIMER

    This  report  has  been funded  wholly  or  1n  part by  the  United  States
Environmental  Protection  Agency under  Contract  No.  68-03-3112  to  Syracuse
Research Corporation.  It has been  subject  to  the Agency's peer and adminis-
trative review, and  H has been  approved  for  publication as an EPA document.
Mention of  trade  names or commercial  products  does  not  constitute  endorse-
ment or recommendation for use.
                                      11

-------
                                    PREFACE
    This report  summarizes  and evaluates Information relevant  to  a prelimi-
nary  Interim  assessment of adverse  health  effects associated  with cls-1,2-
dlchloroethylene.   All  estimates   of   acceptable  Intakes  and  carcinogenic
potency presented  1n  this document  should  be considered as  preliminary  and
reflect limited  resources  allocated to  this  project.   Pertinent  toxlcologlc
and environmental  data were  located  through on-line literature  searches  of
the Chemical  Abstracts,  TOXLINE,  CANCERLINE and  the  CHEMFATE/DATALOG  data
bases.  The basic  literature  searched  supporting  this document  1s  current  up
to September, 1984.   Secondary sources of Information  have also  been relied
upon  1n the  preparation of  this   report  and  represent large-scale  health
assessment  efforts  that  entail   extensive   peer  and   Agency  review.   The
following  Office of  Health  and Environmental  Assessment (OHEA)  source  has
been extensively utilized:


    U.S.  EPA.    1980a.   Ambient Water Quality  Criteria for  Dlchloro-
    ethylenes.   Environmental  Criteria  and  Assessment   Office,  Cincin-
    nati, OH.  EPA 440/5-80-041.  NTIS PB 81-117525.
    The Intent 1n these assessments  1s  to  suggest  acceptable exposure levels
whenever sufficient data  were  available.   Values were not  derived  or larger
uncertainty  factors  were  employed  when the  variable data  were limited  In
scope tending  to  generate conservative  (I.e.,  protective)  estimates.   Never-
theless, the  Interim  values  presented reflect the relative  degree  of hazard
associated with exposure or risk to the chemlcal(s) addressed.

    Whenever possible, two categories of values  have  been  estimated for sys-
temic toxicants (toxicants for which  cancer  1s  not the endpolnt of  concern).
The  first,  the AIS  or acceptable  Intake  subchronlc, 1s  an estimate  of  an
exposure  level  that  would  not  be  expected  to cause  adverse  effects  when
exposure occurs during a  limited  time  Interval  (I.e., for  an  Interval  that
does not  constitute a  significant  portion of  the Hfespan).   This  type  of
exposure estimate  has not been  extensively used  or  rigorously  defined,  as
previous  risk  assessment  efforts  have  been  primarily  directed  towards
exposures from toxicants  1n  ambient air or water  where  lifetime exposure  Is
assumed.   Animal  data  used  for  AIS estimates  generally  Include  exposures
with durations of 30-90  days.  Subchronlc  human data are  rarely available.
Reported exposures are usually  from chronic  occupational  exposure situations
or from reports of acute accidental exposure.

    The  AIC,  acceptable  Intake  chronic,   1s  similar   1n  concept to  the  ADI
(acceptable  dally Intake).   It 1s  an estimate of  an  exposure level  that
would not  be expected  to cause adverse effects when exposure  occurs  for  a
significant portion of the  Hfespan  [see  U.S.  EPA (1980b)  for  a discussion
of  this  concept].   The   AIC  1s   route specific  and  estimates  acceptable
exposure  for  a given  route  with  the  Implicit  assumption that  exposure  by
other routes 1s Insignificant.
                                      111

-------
    Composite  scores   (CSs)  for  noncardnogens  have also  been  calculated
where data permitted.   These  values  are used for  ranking  reportable  quanti-
ties; the methodology for their development -1s explained  1n U.S.  EPA (1983).

    For compounds for which there  1s  sufficient  evidence  of  cardnogenldty,
AIS  and  AIC values  are not derived.   For a  discussion  of risk  assessment
methodology  for  carcinogens  refer to  U.S. EPA  (1980b).   Since  cancer  1s  a
process that  Is  not characterized by  a threshold, any exposure  contributes
an Increment of  risk.   Consequently,  derivation of AIS and  AIC  values  would
be Inappropriate.   For  carcinogens,   q-|*s  have been  computed  based on  oral
and Inhalation data 1f available.
                                      1v

-------
                                   ABSTRACT


    In  order  to  place the  risk  assessment  evaluation  1n proper  context,
refer  to  the preface  of   this  document.  The  preface  outlines  limitations
applicable  to  all  documents  of  this   series  as  well  as the  appropriate
Interpretation and use of  the quantitative estimates presented.

    Data were  Inadequate  to  estimate  AIS or AIC  values for  either  oral  or
Inhalation  routes.   Data  were  also  Inadequate  to  assess  the  carcinogenic
potency of this  chemical.

-------
                               ACKNOWLEDGEMENTS
    The  Initial  draft  of  this  report  was  prepared  by Syracuse  Research
Corporation  under  Contract No.  68-03-3112 for  EPA's  Environmental  Criteria
and  Assessment  Office,  Cincinnati,   OH.   Or.  Christopher  DeRosa and  Karen
Blackburn were the Technical  Project  Monitors  and Helen Ball  was^the Project
Officer.  The final documents  1n  this series  were prepared  for the Office of
Emergency and Remedial Response, Washington, DC.

    Scientists from  the  following U.S. EPA offices  provided  review comments
for this document series:

         Environmental Criteria and Assessment Office, Cincinnati, OH
         Carcinogen Assessment Group
         Office of A1r Quality Planning and Standards
         Office of Solid Waste
         Office of Toxic Substances
         Office of Drinking Water

Editorial review for the document series was provided by:

    Judith Olsen and Erma Durden
    Environmental Criteria and Assessment Office
    Cincinnati, OH

Technical support services for the document series was provided by:

    Bette Zwayer, Pat Daunt, Karen Mann and Jacky Bohanon
    Environmental Criteria and Assessment Office
    Cincinnati, OH
                                      v1

-------
TABLE OF CONTENTS

1.
2.


3.










4.








5.


ENVIRONMENTAL CHEMISTRY AND FATE 	
ABSORPTION FACTORS IN HUMANS AND EXPERIMENTAL ANIMALS . . .
2.1.
2.2.
ORAL 	
INHALATION 	
TOXICITY IN HUMANS AND EXPERIMENTAL ANIMALS 	
3.1.


3.2.


3.3.


3.4.
SUBCHRONIC 	
3.1.1. Oral 	
3.1.2. Inhalation 	
CHRONIC 	
3.2.1. Oral 	
3.2.2. Inhalation 	
TERATOGENICITY AND OTHER REPRODUCTIVE EFFECTS. . . .
3.3.1. Oral 	
3.3.2. Inhalation 	
TOXICANT INTERACTIONS 	 	
CARCINOGENICITY 	
4.1.


4.2.


4.3.
4.4.
HUMAN DATA 	
4.1.1. Oral 	
4.1.2. Inhalation 	
BIOASSAYS 	
4.2.1. Oral 	
4.2.2. Inhalation 	
OTHER RELEVANT DATA 	
WEIGHT OF EVIDENCE 	
REGULATORY STANDARDS AND CRITERIA 	
Page
1
3
. . . 3
3
4
4
. . . 4
4
, , 5
. . . 5
5
5
. . . 5
, , , 5
5
, . . 6
6
. . . 6
6
, , 6
. . . 6
6
. . . 6
7
. . . 8

-------
                          TABLE OF CONTENTS  (cent.)

RISK
6.1.


6.2.


6.3.



ASSESSMENT 	
ACCEPTABLE INTAKE SUBCHRONIC (AIS) 	
6.1.1. Oral 	
6.1.2. Inhalation 	
ACCEPTABLE INTAKE CHRONIC (AIC) 	
6.2.1. Oral 	
6.2.2. Inhalation 	
CARCINOGENIC POTENCY (q-|*) 	
6.3.1. Oral 	
6.3.2. Inhalation 	
REFERENCES 	
Page
	 9
	 9
	 9
	 9
	 9
	 9
	 9
	 9
	 9
	 9
	 10
APPENDIX:  Summary Table for ds-l,2-01chloroethylene	    14

-------
                             LIST  OF  ABBREVIATIONS

ADI                     Acceptable dally Intake
AIC                     Acceptable Intake chronic
AIS                     Acceptable Intake subchronlc
BCF                     Bloconcentratlon factor
CS                      Composite score
MFO                     Mixed function oxldase
ppm                     Parts per million
STEL                    Short-term exposure limit
TLV                     Threshold limit value
                                      1x

-------
                     1.   ENVIRONMENTAL CHEMISTRY AND FATE

    The relevant  physical  and  chemical properties and environmental  fate  of
ds-l,2-d1chloroethylene (CAS No.  156-59-2)  are given below.

    Chemical class:                 halogenated aliphatic  hydrocarbon
    Molecular weight:              96.95
    Vapor pressure at 25°C:        208 mm Hg (Torkelson and Rowe,  1981)
    Water solubility at  20°C:      3500 mg/a. (Torkelson and Rowe,  1981)
    Octanol/water partition
    coefficient:                   5 (estimated)
    BCF:                           0.8 (estimated)
    Half-lives 1n
      Air:                         1.3 days  (Hendry and Kenly, 1979)
      Water:                       
-------
    Pertinent data  regarding  the  fate of  c1s-l ,2-d1ch1oroethy"lene  in  soil
could not be located in  the  available  literature.    Based on the behavior of
the compound in  aquatic media, evaporation  of  cis-1,2-dichloroethylene  from
the soil surface  is  expected to be the predominant  loss  mechanism.   In  sub-
surface soil, biodegradation of this compound  is  likely  to be a slow process
(Tabak  et  al.,  1981).   Therefore,  the  compound  is  expected  to have  the
potential  to leach  from  subsurface  soil   into   groundwater.   Page  (1981)
reported  cis-1,2-dichloroethylene  in   groundwaters   from  New   Jersey  at  a
frequency of 44%.
                                      -2-

-------
           2.   ABSORPTION  FACTORS  IN HUMANS AND EXPERIMENTAL MAMMALS
2.1.   ORAL EXPOSURE
    Pertinent data  regarding  the  oral  absorption  of  c1s-l ,2-d1chloroethylene
could  not  be  located  1n  the available  literature.  The  U.S.  EPA  (1980a)
estimates  that  "virtually  100  percent  of   Ingested  DCE  may  be  absorbed
systemically,"  based  on  the  studies  of  Daniel  (1963)  and  Monster et  al.
(1976) using trlchloroethylene.
2.2.   INHALATION
    Pertinent data  regarding  the  absorption  of  ds-1,2-d1chloroethylene  from
the respiratory tract could not be located In  the available  literature.   The
U.S.  EPA  (1980a)  estimates that  "35  to  50  percent  of Inhaled  DCE...may  be
absorbed systemlcally," based on  the studies of Daniel  (1963)  and  Monster  et
al. (1976)  using trlchloroethylene.
                                     -3-

-------
                3.   TOXICITY  IN  HUMANS  AND  EXPERIMENTAL  ANIMALS
3.1.   SUBCHRONIC
3.1.1.   Oral.   Springer  (1965) administered  a mixture  of ds- and  trans-
l,2-d1chloroethylene to rats  for  7  weeks  (0.05, 0.25,  0.5  or  1.0  g/kg).   It
was not  clear from the review  1f  these were  dally,  weekly or  total  doses.
No adverse effects  were  reported  at any dose  level.   Pertinent  data regard-
Ing the  subchronlc  oral  toxlclty of pure  ds-1,2-d1chloroethylene  could  not
be located In the available literature.
    ds-1,2-D1chloroethylene administered  to rats as  a  single  dose  of  either
400 or 1500 mg/kg by gavage  1n  corn oil  resulted 1n Increases  1n a series of
hepatic  enzymes  which are  Indicators of  hepatotoxldty.  The authors suggest
that  ds-1,2-d1chloroethylene  Is   a   less  potent   hepatotoxln  than  I,l-d1-
chloroethylene.  In addition, the ds  Isomer  of 1,2-d1chloroethylene appears
to be  slightly  more hepatotoxlc than  the  trans  Isomer  with respect to these
endpolnts (Jenkins et a!., 1972).
3.1.2.   Inhalation.  Exposure  of  rats  for 8  hours  to  trans-1,2-d1chloro-
ethylene  at  a  concentration  of 200  ppm  Induced  fatty degeneration  of  the
hepatocytes  and Kupffer  cells  (Freundt  et a!.,   1977).   In  an  additional
study, exposure  of  rats  for  8  hours  to  a concentration of  200  ppm ds-1,2-
dlchloroethylene  resulted  In Inhibition  of the  MFO  system as  measured  by
hexobarbltal  sleeping  time,  zoxazolamlne  paralysis  time  and  formation  of
4-am1no-ant1pyrene  from   amlnopyrene.   The  c1s  Isomer  was a  more  potent
Inhibitor  than  the  trans  Isomer  (Freundt and  Macholz, 1978).   Subsequent
work  suggests  that  these  effects  are mediated  by a P-450  generated reactive
metabolite which  Interacts  with the heme  moiety at the active  site of P-450
(Costa and Ivanetlch, 1982).  Also,  It Is  probably  nephrotoxlc  by  analogy to
1,1-dtehloroethylene (U.S. EPA,  1980a).
                                      -4-

-------
3.2.   CHRONIC
3.2.1.   Oral.   Pertinent  data  regarding  the  chronic  oral   toxldty  of
c1s-l,2-dlchloroethylene could not be located In the available literature.
3.2.2.   Inhalation.    Pertinent   data   regarding  the  chronic   Inhalation
toxldty of  ds-l,2,-d1chloroethylene  could  not be located  1n  the  available
literature.   In  an unpublished study,  Torkelsen  (1965) reported no  effects
on  growth,  mortality,  organ  and  body weights,  hematology, clinical  chem-
istry,  gross  pathology or  hlstopathology  1n rats,  rabbits, guinea  pigs  or
dogs  exposed  to  500  or   1000  ppm  1,2-d1chloroethylene  (mixed  Isomers)  7
hours/day, 5 days/week for 6 months.
3.3.   TERATOGENICITY AND OTHER REPRODUCTIVE  EFFECTS
3.3.1.   Oral.  Pertinent  data  regarding  the teratogenldty or other  repro-
ductive effects of orally administered  ds-1,2-d1chloroethylene could not  be
located 1n the available  literature.
3.3.2.   Inhalation.    Pertinent  data regarding  the teratogenldty or  other
reproductive   effects   of  inhaled  c1s-l,2-d1chloroethylene  could  not  be
located 1n the available  literature.
3.4.   TOXICANT INTERACTIONS
    Pertinent  data  regarding the  Interactions  of  ds-1,2-d1chloroethylene
with  other  toxicants  could not be located 1n  the available literature.  Due
to  the  effects of ds-1,2-d1chloroethylene on  cytochrome  P-450,  however,  1t
would  be  expected  that  this compound  could  affect  the  toxldty of  other
compounds  that are metabolized by  the MFO system.
                                      -5-

-------
                             4.  CARCINOGENICITY
4.1.   HUMAN DATA
4.1.1.   Oral.   Pertinent  data  regarding  the  cardnogenldty   of   orally
administered cls-1,2-d1chloroethy1ene  1n  humans  could  not be located  In  the
available literature.
4.1.2.   Inhalation.    Pertinent  data   regarding  the  cardnogenldty  of
Inhaled  ds-1,2-d1chloroethylene  In  humans  could  not   be  located  1n  the
available literature.
4.2.   BIOASSAYS
4.2.1.   Oral.   Pertinent  data  regarding  the  cardnogenldty   of   orally
administered  ds-1,2-dlchloroethylene  1n experimental  animals  could  not be
located 1n the available literature.
4.2.2.   Inhalation.    Pertinent  data   regarding  the  cardnogenldty  of
Inhaled  ds-1,2-d1chloroethylene  1n  experimental  animals  could  not  be
located 1n the available literature.
4.3.   OTHER RELEVANT DATA
    Grelm  et al.  (1975)  reported  negative results  for  ds-1,2-dlchloro-
ethylene using  EscheMchla  coll K12  as   the  Indicator  organism.   Cerna  and
Kypenova  (1977)  found  that ds-1,2-d1chloroethylene  was  not  mutagenlc 1n
Salmonella tester strains using the  spot test without metabolic  activation.
ds-1,2-D1chloroethylene was found   to produce a dose-dependent  Increase 1n
mutations using the host-media  bloassay,  however, and also  to Induce chromo-
somal  aberrations as  Indicated by  cytogenlc analysis  of  bone  marrow  cells
Isolated  from mice  given  repeated  1ntraper1toneal  Injections  (Cerna  and
Kypenova, 1977).
    ds-1,2-D1chloroethylene  did  not   Increase  the   recombination   rate,
frequency of  point mutations  or gene conversion  1n  Saccharomyces  cereveslae
(GalU et al., 1982).

                                      -6-

-------
4.4.   WEIGHT OF EVIDENCE
    Pertinent data regarding  the  carclnogenlcity of ds-1,2-d1chloroethylene
In  humans  or  animals  could  not  be  located  1n  the available  literature.
Using  the   criteria   for  evaluating   the  overall  weight  of  evidence  for
carclnogenlcity to humans  proposed by  the  Carcinogen  Assessment  Group of the
U.S. EPA  (Federal  Register,  1984),  cls-1,2-d1chloroethylene  Is  most appro-
priately designated a Group D-Not Classified chemical.
                                      -7-

-------
                     5.   REGULATORY  STANDARDS  AND  CRITERIA







    The  ACGIH  (1980, T983)  has establshed  a TLV  of 200  ppm  (-790  mg/m3)



and  a  STEL  of  250 ppm (-1000  mg/m3)   based  on  an unpublished  study  by



Torkelsen  (1965)  (see  Section  3.2.2.).   This standard does  not  distinguish



between the els and trans Isomers.
                                     -8-

-------
                              6.   RISK  ASSESSMENT
6.1.   ACCEPTABLE INTAKE SUBCHRONIC (AIS)
6.1.1.   Oral.  The available  data  were  Inadequate for the derivation  of  an
oral AIS for ds-1,2-d1chloroethylene.
6.1.2.   Inhalation.  The available data  were  Inadequate  for the  derivation
of an Inhalation AIS for cls-1,2-d1chloroethylene.
6.2.   ACCEPTABLE INTAKE CHRONIC (AIC)
6.2.1.   Oral.  The available  data  were  Inadequate for the derivation  of  an
oral AIC. for ds-l,2-d1chloroethylene.
6.2.2.   Inhalation.  The available data  were  Inadequate  for the  derivation
of  an  Inhalation AIC for  c1s-l,2-d1chloroethylene.   The  data  regarding  the
toxldty  of  ds-1,2  and   trans-1,2-d1chloroethylene  were  Investigated  to
determine  the  suitability  for  derivation  of  CS  values  based  on  chronic
toxldty.   Data were Insufficient  for  derivation  of  a  CS  for  c1s-l,2-d1-
chloroethylene.
6.3.   CARCINOGENIC POTENCY (q^)
6.3.1.   Oral.  Pertinent data  regarding  the  carclnogenldty  of c1s-l,2-d1-
chloroethylene following oral exposure could not be  located 1n  the  available
literature.  Therefore,  no q * could be derived.
6.3.2.   Inhalation.   Pertinent  data  regarding  the  Inhalation  carclno-
genldty of  c1s-l,2-d1chloroethylene  could not be located  1n  the  available
literature.  Therefore,  no q,* could be derived.
                                     -9-

-------
                                7.   REFERENCES

AC6IH  (American  Conference  of  Governmental  Industrial  Hyg1en1sts).   1980.
Documentation of  the  Threshold  Limit Values, 4th  ed.  (Includes  supplemental
documentation, 1981).   Cincinnati,  OH.

ACGIH  (American  Conference  of  Governmental  Industrial  Hyglenlsts).   1983.
TLVs.  Threshold Limit Values for  Chemical  Substances  and  Physical  Agents  1n
the Work Environment with Intended  Changes for 1983-1984.   Cincinnati,  OH.

Cerna,  M.  and  H.   Kypenova.   1977.  Mutagenlc  activity   of  chloroethylenes
analyzed by  screening system tests.   Mutat. Res.   46:  214-215.   (Cited  In
U.S. EPA, 1980a)

Costa,  A.K.   and  K.M.  Ivanetlch.   1982.   The  1,2-d1chloroethylenes:  Their
metabolism by hepatic cytochrome  P-450  in vitro.   Blochem.  Pharmacol.   31:
2093-2102.

Daniel,  J.W.   1963.   The  metabolism of  36C1-labeled tMchloroethylene  and
tetrachloroethylene 1n  the rat.   Blochem.  Pharmacol.  12:  795-802.   (Cited
In U.S. EPA,   1980a)

Federal  Register.   1984.   Environmental  Protection  Agency.   Proposed  guide-
lines for carcinogenic risk assessment.   Federal Register.   49:  46294-46299.

Freundt, K.J. and  J.  Macholz.   1978.  Inhibition  of  mixed function oxldases
1n  rat  liver  by  trans- and  ds-1,2-d1chloroethylene.    Toxicology.   10:
131-139.

                                     -10-

-------
Freundt, K.J., 6.P.  Llebaldt  and  E.  Liberwirth.  1977.  Toxldty  studies  on



trans-1,2-d1chloroethylene.   Toxicology.   7:  141-153.







GalU, A.,  et al.    1982.   Genetic  effects  of  1,2-d1chloroethylene.   1.  In



vitro study.  Boll. Soc.  Ital. B1ol.  Sper.   58:  860.







Grelm,  H.,   G.   Bonse,  Z.  Radwan,   D.   Relchert  and  D.  Henschler.   1975.



Mutagenlclty jm  vitro and potential cardnogenldty of  chlorinated ethylenes



as  a  function  of   metabolic  oxlrane  formation.   Blochem.  Pharmacol.   24:



2013-2017.   (Cited  in U.S.  EPA,  1980a)







Hendry,  O.G.  and  R.A.  Kenley.   1979.    Atmospheric  reaction  products  of



organic  compounds.   Office  of  Toxic  Substances,  U.S.  EPA,  Washington,   DC.



EPA 560/12-79-001.
Jenkins,  L.J.,   Jr.,  M.J.  Trabulus  and  S.D.  Murphy.   1972.    Biochemical



effects of  1 ,l-d1chloroethylene  in  rats: Comparisons with carbon  tetrachlo-



ride  and   1,2-d1chloroethylene.   Toxlcol.  Appl.  Pharmacol.   23:   501-509.



(Cited in  U.S. EPA, 1980a)







Kenaga, E.E.  and  C.A.I.  Goring.   1980.  Relationship  between  water  solu-



bility,  soil  sorptlon,   octanol-water   partitioning  and  concentration  of



chemicals  in  biota.  in:  Aquatic  Toxicology,  ASTM STP 707,  J.G.  Eaton, P.R.



ParMsh and  A.C.  HendMcks, Ed.   Am.  Soc. Test.  Mater.,  Philadelphia,  PA.



p. 78-115.
                                     -11-

-------
Mabey, W.R.,  J.H.  Smith,  R.T.  Podoll, et  al.   1981.  Aquatic  fate  process



data  for  organic  priority pollutants.   Monitoring  and  Data Support  D1v.,



OWRS, U.S. EPA, Washington, DC.   EPA 440/4-81-014.







Monster,   A.C.,  G.  Boersma  and  W.C.  Duba.    1976.   Pharmacok1net1cs  of



trlchloroethylene  1n  volunteers,  Influence of  workload  and exposure  con-



centration.   Ind. Arch. Occup. Environ. Health.  38:  87-102.   (Cited  In U.S.



EPA, 1980a)







Page, 6.W.   1981.   Comparison  of groundwater and surface  water  for  patterns



and  levels   of  contamination  by  toxic substances.   Environ. Scl.  Techno!.



15: 1475-1481.







Springer,  E.   1965.    No  titled  provided.   Ztschr.  f.d.g.  Hyg.  u.  1hre



Grenzgeblete.  11: 442.  (Cited 1n ACGIH,  1980)







Tabak, H.H.,  S.A.  Quare,   C.I.  Mashnl and E.F.  Barth.   1981.   Blodegrad-



abllHy studies  with  organic  priority  pollutant  compounds.  J.  Water  Pollut.



Control Fed.   53: 1503-1518.







Torkelsen,  T.R.   1965.   Communication  to  TLV  Committee,   Dow Chem.  Co.,



December,.  (Cited In ACGIH, 1980}







Torkelson,  T.R.  and  V.K.  Rowe.   1981.  Halogenated  aliphatic  hydrocarbons.



ITK  Patty's  Industrial  Hygiene and  Toxicology,  Vol.  28,  3rd rev.  ed., G.D.



Clayton and  F.E. Clayton, Ed.   John Wiley and Sons,  NY.   p. 3550.
                                     -12-

-------
U.S.  EPA.    1980a.   Ambient  Water  Quality  Criteria for  Dlchloroethylenes.
Environmental   Criteria   and   Assessment   Office,   Cincinnati,  OH.    EPA
440/5-80-041.  NTIS PB 81-117525.

U.S.  EPA.   1980b.   Guidelines  and Methodology  Used 1n  the Preparation  of
Health  Effects  Assessment  Chapters  of  the  Consent  Decree  Water  Quality
Criteria.  Federal Register.  45:79347-79357.

U.S.  EPA.   1983.   Methodology and Guidelines  for  Reportable  Quantity Deter-
minations  Based  on  Chronic  Toxldty  Data.   Prepared  by the  Environmental
Criteria and Assessment Office,  Cincinnati,  OH,  OHEA for  the  Office  of Solid
Waste and Emergency Response,  Washington, DC.

Veith, G.D., D.L. Defoe and B.V.  Bergstedt.   1979.   Measuring  and estimating
the bloconcentratlon  factor  of chemicals  1n  fish.   J.  F1sh Res.  Board  Can.
36: 1040-1048.
                                     -13-

-------
ro
                                                          APPENDIX
' _ o
L. =J
) s 3
: ''\ 3
. ~~ TJ
3 TJ
"i O
r-t-
CD
S a
" 9
2 Inhalation
era
S AIS
^ AIC
Oral
i AIS
1
AIC
Summary Table for c1s-l,2-D1chloroethylene

Species Experimental Effect
Dose/Exposure

ND ND ND
ND ND ND

ND ND ND
ND ND ND

Acceptable Intake Reference
(AIS or AIC)

ND ND
ND ND

ND ND
ND ND
         ND  -  Not  derived

-------